Marvin Test Solutions Secures $3.2M Order for Modular Military Precision Guided Target Simulators

IRVINE, Calif., June 10, 2014 /PRNewswire/ -- Marvin Test Solutions, a trusted provider of globally deployed innovative test solutions for military, aerospace, and manufacturing organizations today announced it garnered a $3.2M contract for its MTS-916 Modular Target Simulators from an overseas military customer. A state-of-the-art target simulator for optically guided weapons, the MTS-916 replaces multiple obsolete target simulators for AGM-65, TGM-65 Maverick, and AGM-114 Hellfire missiles and guidance sections, as well as MAU-169 Paveway target seeker kits.

"We have a long and successful history designing and developing innovative military systems to make test easy and overcome obsolescence. We used this experience to create the MTS-916 and to meet the critical need for an accurate and reliable target simulator that can reliably test the new generation of optically guided weapons and integrate seamlessly with legacy maintenance and sustainment systems," said Major General Steve Sargeant, USAF (Ret.), and CEO of Marvin Test Solutions. "In addition to being highly sought after to replace wide-spread obsolescence in target simulators, the MTS-916 is also a cost-effective solution."

The MTS-916 combines visible TV/CCD, infrared (IR), and laser seeker support into a rugged, compact system. Its modular design features two main subassemblies, simplifying system repair and maintenance. The MTS-916 offers maintainers a ruggedized system that meets MIL-STD-810 temperature, shock, vibration, and humidity requirements as well as MIL-STD-461 EMI specifications. It can be used for I-level and D-level maintenance and can also operate in harsh environments. Since its release, the MTS-916 has been successfully deployed globally in many countries.

MTS-916 and MTS-206 Provide a Rugged Flightline Solution
Used in conjunction with the state-of-the-art MTS-206 portable test set for the AGM-65 Maverick and AGM-114 Hellfire Missile systems, the MTS-916 target simulator delivers high reliability, offers a reduced footprint, and features better automation than the legacy test sets it replaces. The combination of the MTS-206 and MTS-916 provides a rugged flightline solution for testing, troubleshooting, and boresighting of missiles.

The MTS-916 target simulator is compatible with the legacy AN/DSM-157 guided missile test set (GMTS) and is designed to replace the manually operated AN/DSM-129 and AN/DSM-787 legacy target simulators.

About Marvin Test Solutions
Marvin Test Solutions is a vertically integrated aerospace test and measurement company that has delivered innovative solutions for factory, flightline, intermediate-level, and depot-level applications since 1988. As a member of the Marvin Group, an award-winning aerospace company with a 50-year history in the Defense and Commercial Aerospace industries, Marvin Test Solutions has test systems deployed in support of most of the major defense aircraft and munitions in use around the world. Marvin Test Solutions delivers full-spectrum test solutions that make test, maintenance, and sustainment of the most mission-critical systems easier and less costly.

Media/Customer Contact: Mike Dewey, MikeD@marvintest.com

SOURCE Marvin Test Solutions

reade more... Résuméabuiyad

Coherus BioSciences Secures $55 million Series C Financing

Coherus BioSciences Logo. (PRNewsFoto/Coherus BioSciences)jwplayer.key="2kY/GKwZ2uQZmDlQ9VYArfZt2b4+KhHX3+DM4zisgtE=";REDWOOD CITY, Calif., May 19, 2014 /PRNewswire/ -- Coherus BioSciences, Inc. ("Coherus"), a leading biologics platform company focused on biosimilars, announced today the closing of a Series C Preferred investment round raising $55 million. New investors KKR & Co. L.P. ("KKR"), Venrock, RA Capital Management, Rock Springs Capital and Fidelity Biosciences joined existing investors Sofinnova Ventures, Lilly Ventures and Vivo Capital in the transaction.

"We are very pleased to have the confidence and financial support of such an extraordinary group of health care investors," said Denny Lanfear, President and CEO of Coherus. "Since its founding four years ago, Coherus has made excellent progress on its goals of moving biosimilar biologics into Phase 3 trials and onto the market. The capital resources provided by our investors will allow us to prosecute our development plans, optimize our partnering strategies and deliver essential therapeutics to patients faster."

As part of the transaction, Ali Satvat, Director on KKR's health care investing team, will join the Board of Directors of Coherus. "We are excited to support Denny and his experienced team on their growth initiatives to transform the biologics market," said Mr. Satvat. "We believe that the Coherus platform is well-positioned to succeed given its product pipeline and strong scientific and technical capabilities."

Since its inception, Coherus has raised over $220 million from equity and non-dilutive licensing fees and milestones.

About Coherus BioSciences, Inc.

Coherus is a leading biologics platform company focused on delivering high-quality biosimilar therapeutics that will expand patient access to life-changing medications worldwide. Headquartered in the San Francisco Bay Area and founded by a group of biotech pioneers who helped build America's first generation biotherapeutics industry, Coherus has developed a collaborative business model that leverages a strategic consortium of service providers aligned through ownership and shared incentives. Coherus' global commercialization partnerships include top-tier biopharma companies in Europe, Asia, and Latin America.

Biosimilars are intended for use in place of existing, branded biologics to treat a range of chronic and often life-threatening diseases, with the potential to reduce costs and expand patient access. For additional information, please visit www.coherus.com.

Contact – Beth Jimison – bjimison@coherus.com  650.649.3526

Logo - http://photos.prnewswire.com/prnh/20120507/SF01448LOGO

SOURCE Coherus BioSciences, Inc.

RELATED LINKS
http://www.coherus.com

reade more... Résuméabuiyad

Biometric Identification System from SRI International Secures Access to E-Commerce Park Data Center in Curaçao

MENLO PARK, Calif., Feb. 25, 2014 /PRNewswire/ -- SRI International Sarnoff's Iris on the Move® (IOM) N-Glance™ biometric system is now protecting access to E-Commerce Park Curaçao, the first data center of its kind built in the Pan Caribbean area. E-Commerce Park provides clients with redundant continuity and disaster recovery solutions, including colocation, data storage and private cloud services. IOM N-Glance systems secure access to the colocated servers and data housed at E-Commerce Park Data Center by confirming the identity of authorized employees as they enter the facility as well as the colocation areas.

"A high level of security is critical to our business, where we manage network operations, client support, and redundant Internet access day and night," said Rob Vermeulen, CEO of E-Commerce Park. "Our clients entrust us with business-critical data, and the N-Glance iris recognition system ensures the most accurate method of identity verification of people entering our sensitive facilities."

SRI's IOM N-Glance system is easy to use and non-intrusive. Users simply glance at the system from a comfortable distance to confirm identity and gain access. The system identifies people in less than a second and processes up to 12 people per minute. It captures iris images even if a user is wearing eyeglasses or contact lenses.

"Positive identity authentication is essential for protecting intellectual property and physical IT infrastructure," said Mark Clifton, vice president, Products and Services Division at SRI International. "SRI's N-Glance systems will provide E-Commerce Park Data Center and its clients with trusted identity management in an easy-to-use, practical way."

About E-Commerce Park
E-Commerce Park N.V. is located in Curaçao (www.e-commercepark.com) and in operation since November of 2001. As the first built-for-purpose data center in the Caribbean, ECP is one of the most trusted and stable facilities in the Pan Caribbean region. With 2N redundancies on power, cooling as well as multi-homed network access, ECP is the ideal location for enterprises seeking secure and reliable colocation services. Since August 2007, E-Commerce Park is part of Columbus International, one of the largest telecommunication providers in the Caribbean (www.columbus.co).

For more information on E-Commerce Park, please visit our website or email sales@e-commercepark.com.

About SRI International

SRI International is a nonprofit research and innovation center headquartered in Silicon Valley. Government and business clients worldwide come to SRI for pioneering solutions in biomedical sciences and health, chemistry and materials, computing, education, economic development, energy, security and defense, robotics, sensing, and more. We provide research, laboratory and advisory services, technology development and licenses, deployable systems, products, and venture opportunities. Our innovations have created new industries and marketplace value, and lasting benefits to society. 

Visit SRI's website and Timeline of Innovation to learn more.

SOURCE SRI International

RELATED LINKS
http://www.sri.com

reade more... Résuméabuiyad